Related Experiment Video
Updated: Aug 3, 2026

10:17
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
Published on: November 3, 2010
A genetic analysis of processes regulating cytochrome P4501A1 expression
1Laboratory of Structural Biology and Molecular Medicine, University of California, Los Angeles 90024.
Advances in Enzyme Regulation
|January 1, 1994
Summary
Researchers isolated mouse hepatoma cell mutants deficient in cytochrome P4501A1 (CYP1A1) inducibility. A dominant mutant protein blocked the aryl hydrocarbon (Ah) receptor
Area of Science:
- Molecular Biology
- Toxicology
- Genetics
Background:
- Cytochrome P4501A1 (CYP1A1) and its aryl hydrocarbon hydroxylase activity are inducible in Hepa-1 cells by compounds like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
- Mutant Hepa-1 cell lines deficient in CYP1A1 inducibility were generated to study the regulatory mechanisms.
- Some mutants exhibited a dominant phenotype, suggesting alterations in repressor gene activity.
Purpose of the Study:
- To isolate and characterize mutants of the Hepa-1 cell line with defects in CYP1A1 inducibility.
- To elucidate the genetic basis of CYP1A1 induction regulation.
- To identify the proteins and genes involved in the aryl hydrocarbon (Ah) receptor signaling pathway.
Main Methods:
- Isolation of mutant Hepa-1 cell lines resistant to CYP1A1 induction.
- Phenotypic analysis of mutants, including dominant and recessive characterization.
- Complementation analysis to assign recessive mutants to different complementation groups (genes).
- Cloning of a cDNA for gene C (ARNT) and characterization of its encoded protein.
Main Results:
- A dominant mutant expressed a protein inhibiting the liganded aryl hydrocarbon (Ah) receptor's DNA binding to the xenobiotic responsive element (XRE).
- Recessive mutants were assigned to four complementation groups, likely representing four distinct genes.
- Gene A is the CYP1A1 structural gene; genes B, C, and D affect Ah receptor function.
- The cloned gene C encodes ARNT, essential for ligand-dependent Ah receptor nuclear translocation and XRE binding.
- ARNT and the Ah receptor form a heterodimeric complex that directly binds the XRE, both containing basic helix-loop-helix motifs.
Conclusions:
- Genetic alterations in Hepa-1 cells can disrupt CYP1A1 inducibility through various mechanisms, including dominant repression and defects in Ah receptor pathway components.
- ARNT (from gene C) is a crucial component of the Ah receptor complex, mediating its DNA binding activity.
- The identified genes (A, B, C, D) represent key elements in the regulation of CYP1A1 gene expression and xenobiotic metabolism.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

